chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received 2 shots/ had it on my face and in my my mouth/ suspected vaccination failure; I had it on my face and in my my mouth on the right side gosh; in pain\ it was that painful; couldn't eat; This case was reported by a consumer via  interactive digital media and described the occurrence ofsuspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (about 11 years ago).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and unable to eat. On an unknown date, the outcome of the vaccination failure, shingles, pain and unable to eat were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, pain and unable to eat to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had shingle shot about 11 years ago then it was only 50 percent active that's why he/she got it a 4th time shot. The patient stated he/she received two Shingles shots earlier this year both were 95 percent active. The patient stated he/she the 4th time had it on face and in mouth on the right side gosh was in pain, he/she could not eat for two weeks it was that painful. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Mom stated on 12/30/00 in the afternoon that she noticed a spot on 1 cheek of face and thought it was like a pimple, but filled with yellow fluid. On 12/31/01, he had about 10 of these on his abdomen. Did not think he ran a fever, but has been cranky. Mother is not aware of any exposure to chickenpox. Advised to contact MD. MD appointment on 1/2/02 and was dx'd with chickenpox.
Patient friend claims that he developed gout after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (Patient friend claims that he developed gout after receiving the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GOUT (Patient friend claims that he developed gout after receiving the vaccine). At the time of the report, GOUT (Patient friend claims that he developed gout after receiving the vaccine) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.      Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow-up information received on 28-MAY-2021, contains no new information.
INitally, within the first 24 hours, I had many body aches, and felt tired.  Took Tylenol dosage appropriately for the next 12 hours and was back to normal.  On day 8, last night, I noticed itching on my injection site, and saw big red welts with hot to touch, painful, endurated.  This morning, it is improving less red, less raised, warm to touch, and less painful.  Still endurated moderately.
pt recv vax & pt's SGPT inc to 1.5 times the nl level; No further details were provided;
Patient complained of itchiness around B/L arm and chest and stated he has history of itchiness and takes Benadryl at home. Patient is allergic to Xolair and other environmental facts which results in itchiness. On thorough assessment no difficulty breathing, swelling of throat and lips noted. Vital signs initiated.  Benadryl 25 mg PO given. After few minutes patient stated his itchiness subsided and was ready to leave observation area. Thorough assessment and last set of vital signs taken. Patient left observation are in stable condition.
Arm pain, muscle pain, redness, swelling, and palpable eat at injection site for more than 48 hours post injection. Myalgia day after injection- 12-24 hours after.
Flushing/itching. BP 147/104 (pulse 85), 97% O2 sat. Final BP 133/96 (pulse 78), 96% O2 sat. Benadryl 25 mg PO given.
FEVER OF 104.7F; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 04-AUG-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 05-AUG-2021, the subject experienced fever of 104.7f. On 05-AUG-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 104.7 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever of 104.7f, and headache. This report was non-serious.
Subsequently starting on 2/17/00, the pt experienced significant local swelling (twice as big), hot to the touch, redness, pain and tenderness at the injection site. He could not walk. The most recent information received on 2/18/00 reports the outcome of the pt as resolved.
Days one and two:  chills and body aches.  Days 1-7 fatigue.  Approximately on days 3-7 on/off headache.  Starting with day 3 brain fog off and on as well as seemingly blurred vision off and on...this spacey experience seems to be fading by end of day 8.  I'll note ITEM 20 as unknown as a result.
First time in my life, menstruation cycle is 12 days early than planned with thick clot droppings. Also breast size got bigger too, it was 34 before and now its 36
with symptoms similar to pneumonia for some time; This spontaneous report has been received from a lawyer, via a  FactSheet from a case in litigation for zoster vaccine live (ZOSTAVAX) (MARRS # 1907USA012306), concerning an elderly female patient.  On an unspecified day in 2010, the patient received Pneumococcal Vaccine (+) Polyvalent (23-valent) (PNEUMOVAX 23) (reported as PNEUMOVAX) (strength, dose, route, anatomical location, lot# and expiration date were not reported) as prophylaxis.  On an unspecified date, the patient presented with symptoms similar to pneumonia (Pneumonia) for some time.  The causality assessment between Pneumococcal Vaccine (+) Polyvalent (23-valent) (PNEUMOVAX 23) and the event symptoms similar to pneumonia was considered as related.  Upon internal review, pneumonia was determined to be medically significant.  Upon internal review, the case 1907USA012306, previously submitted with zoster vaccine live (ZOSTAVAX) and Pneumococcal Vaccine (+) Polyvalent (23-valent) (PNEUMOVAX 23) has been split per internal guidelines to capture separately the adverse events related to Pneumococcal Vaccine (+) Polyvalent (23-valent) (PNEUMOVAX 23).; Sender's Comments:  US-009507513-1907USA012306:
Right sided lymph node swelling, febrile to 100.8F, significant swelling of right side of neck.  By 9/9 progressed to right sided facial paralysis.
have been having like constant Tinnitus on her left ear; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 11Mar2021 (Lot number: EN6204) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Tinnitus" (unspecified if ongoing), notes: she had this in the past. The patient's concomitant medications were not reported. The following information was reported: TINNITUS (non-serious) with onset Mar2021, outcome "unknown", described as "have been having like constant Tinnitus on her left ear". Additional information: The patient had her first Pfizer vaccine on 11Mar2021, and since then she have been having like constant tinnitus on her left ear and she just worried about getting the second vaccine as she was reading online that some people had problem too, like 100 of people and some people have hearing loss. So, it made her worried because she haven't existing a hearing loss and she had since this (tinnitus) in past but it was not like this constant. Upon reconfirmation what happen to her left ear: consumer (reporter) stated, " Ya, Tinnitus its like ringing constant ringing on my left ear like Cricket you know."  No follow-up attempts are possible. No further information is expected.
Awoke with chills and fever.  Took 2 ibuprofen.  Took temperature at 2am and had 101, so I took 2 more ibuprofen.  Fever broke.  I felt bad all day 12/12/2009, but was back to normal by 12/13/2009.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Medium, Systemic: Nausea-Mild, Systemic: Shakiness-Medium, Systemic: Weakness-Mild, Additional Details: Patient lost consciousness approximately 30 seconds after administration of vaccine. Patient was lightly convulsing and was unresponsive. EMS was called. Nurse practitioner assisted caring for patient until EMS arrived. Patient recovered quickly and was monitored by EMS for a short while. Patient declined hospitalization.
FLU LIKE SYMPTOMS; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol user drinks 2-3 every other day, and cigarette smoking 3-4 times per day, and other pre-existing medical conditions included the patient had no medical history, no known allergies and no history of drug abuse/ illicit drug use.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the subject experienced flu like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from flu like symptoms. This report was non-serious.
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. Doses of VAQTA (dose, frequency, lot# and route were not reported) which were exposed to temperatures outside of the recommended range, were administered to unspecified patients on unspecified dates since 09-APR-2015. No adverse experience had been observed or reported. No product quality complaint (PQC) was involved. This is one of several cases reported by the same reporter. Additional information has been requested.
Information has been received from a registered nurse concerning a 4 month old male who on 21-DEC-2007 was vaccinated with the second dose Rotateq.  On 27-DEC-2007, because of a clerical error the patient received another dose of Rotateq.  No problems were noted.  Additional information has been requested. 06/02/2008 Information has been received from a registered nurse concerning a 17 week old male, with no medical history and no allergies, who on 21-DEC-2007 was vaccinated with a second PO dose ROTATEQ (Lot# 657359/0507U). Concomitant vaccine administered on 21-DEC-2007 included a second intramuscular dose of PEDIARIX (Lot# AC21B125BB). On 27-DEC-2007, because of a clerical error the patient received another PO dose of ROTATEQ (Lot# 657359/0507U). Concomitant vaccinations administered on 27-DEC-2007 included a second intramuscular dose of PEDVAXHIB (MSD) (Lot# 652502/0719R) and a second intramuscular dose of PREVNAR (Lot# 8539868). There was no illness at the time of vaccination and no adverse events following prior vaccination. No problems were noted. There were no laboratory or diagnostic tests performed. Additional information has been requested.
This vaccine was given to my 4 month old which caused a fever of 102 and higher for 4 days. I am VERY upset
ORANGE PLASTIC BODY OF THE SYRINGE WAS CRACKED CAUSING THE VACCINE TO SQUIRT ONTO THE TABLE UPON PRESSING OF THE PLUNGER.  DOSE WAS READMINISTERED
Pneumovax given Intramuscular, right deltoid, 10 minutes later patient complained of pain, swelling, and redness in right deltoid.  Ice pack applied, physician notified at 2:25pm.  Local reaction.
pt was given td injection 1/23/23. expiration date was 1/22/23
I began with leg swelling in both legs from the ankle to the knee I thought my thighs were swollen but not sure.; Starting today with itchy skin from my both feet to my  knee caps.; I am still experiencing Itchy and redness, not sure if red; I am still experiencing Itchy and redness, not sure if red, because of the lighting in my apartment but it is itchy and painful.; This is a spontaneous report from a non-contactable consumer or other non hcp.    A 62-years-old female patient received First Dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection,Batch/Lot Number: EK4176) via an unspecified route of administration on 03Feb2021 as SINGLE DOSE for an unspecified indication. Medical history included drug hypersensitivity from an unknown date if ongoing.The patient's concomitant medications were not reported. On the 05Feb2021,patient stated that, I began with leg swelling in both legs from the ankle to the knee I thought my thighs were swollen but not sure. Starting today with itchy skin from my both feet to my  knee caps. I went to Clinic and they gave me a prescription for the later pill, I can't remember the name,  if it was lasix, patient said yes. Patient stated that, because my legs were swollen, and they didn't see any reason to give me anything else. I am still experiencing Itchy and redness, not sure if red, because of the lighting in my apartment but it was itchy and painful. Is this a side effect. If he gives me an antibiotic is it advisable. The outcome of the events was not resolved on Feb 2021.   No follow up attempts are possible. No further information is expected.
General yucky feeling; Fever; Chills; Nausea; Swollen lymph nodes; Fatigue; Muscle aches; Headache; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 14:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 1 and irritable bowel syndrome-diarrhea (IBS-D). The patient was allergic to tuberculosis (TB) skin test and curry. Concomitant medications included insulin lispro (HUMALOG) and loratadine (CLARITIN) since an unknown date for unknown indication. The patient previously received unspecified meningitis vaccine (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced allergy to vaccine. The patient also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in left arm on 08Mar2021 at 13:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 01:00, the patient experienced fever, chills, nausea, swollen lymph nodes, fatigue, muscle aches, headache and general yucky feeling. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fever, chills, nausea, swollen lymph nodes, fatigue, muscle aches, headache and general yucky feeling were resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Information has been received from a health professional concerning a 10 year old female student who on 03-SEP-1999 was vaccinated subcutaneously in her left arm with a second dose of VARIVAX (Oka/Merck) (lot # 661857/1215X).  It was also reported that the patient was administered a second of influenza virus 3v reassortant vaccine live intranasal (cold adapted Ann Arbor master strain) (FLUMIST) (lot # 500544P).  It was unknown if there was any illness at the time of vaccination.  On 06-NOV-2008 the patient experienced swelling and redness at injection site.   At the time of this report, the outcomes were unknown.  Additional information has been requested.
Red sore swollen right arm were PPV vaccine given (11/15/02) followed by few days later URI and cold cough, muscle aches and pains lasted ten days.
The vaccine was administered into my upper left arm. At the time of administration I questioned the nurse about the extra pain that was noted during injection. I also noticed that the bandaid was placed rather high, above normal deltoid injection areas. Since the administration, my left arm has had increased pain with movement and decreased strength. My upper arm has pain when lifting above my head and also when rotating it. I have taken ibuprofen to help with the pain but it does not help. I sent a notification to my primary provider and have not heard back yet at this time. I have no history of left arm pain or trauma.
Unknown - Unable to reach patient's guardian or patient himself to inquire. Unable to confirm whether or not patient has experienced an adverse event at this time. Patient or his guardian have not been in contact to report an adverse event.
heart aches; flu like symptoms; fever; aches; headaches; back aches; This is a spontaneous report from a contactable consumer (patient). This 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the 2nd dose (lot number: EN6200) on 24Feb2021 at age of 76 years old, at the 3rd dose (lot number: FF2588) on 05Oct2021 at 02: 30 AM at age of 77 years old; both via an unspecified route of administration in the left arm as single dose for COVID-19 immunization. Medical history included heart issues. Concomitant medications were unknown. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously receive the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) on 03Feb2021 via an unspecified route of administration in the left arm at age of 76 years old as single dose for COVID-19 immunization. The patient had flu like symptoms, fever, aches, headaches after both the second and third injections, also heart aches and back aches too, on 05Oct2021. No treatment was received for the events. No hospitalization prolonged. Outcome of the events was recovered on Oct2021. This report was reported as non-serious.   Follow-up attempts are completed. No further information is expected.
Incorrect vaccine type, administered monovalent COVID19 dose instead of bivalent    rash on arm and face that lasted for one day
Pt recvd vax 17JUN93 & 10JUL93 pt devel fever 102, myalgias, back & leg pain; few days later devel lt leg weakness, 8 months later weakness persists; EMG shows pure motor neuropathy;
Patient began to notice swelling and tingling sensation to right side of face later in the day after getting the vaccine, 11/1/16. On 11/8/16 patient made an appt. to see Dr. who diagnosed him w/Bells Palsy r/t vaccine.
No adverse events were reported. Vaccine was given 3 hours after it was supposed to be used, vaccine could have been expired.
Had systems of fatique and chest pain. Went to hospital of 4/12/2021 . Learned that had blood clots in lungs that I previously did not
About 3 hours later, I broke out in systemic rash ; fairly mild reaction- all over; particular in the trunk. I went to the nurse who gave me the vaccine: from them - I took one dose of Benadryl - one dose took care of it . I was really tired, nauseated and light headed for the next two days.
5X7 RED RAISED SKIN ON BACK OF ARM WITH RED LINES COMING OUT TO ELBOW
rash on backs of both hands and wrists (upper and lower, both)- this has continued to this day and has spread lightly up both arms to just above the elbows- worst is on the back of the hands
Patient's arm began to itch and swell, also radiated heat. This has been going on for about 3 days. I advised patient to take Benadryl to hopefully stop reaction, but also to use a cold compress to help with warm feeling.
Left thigh swollen, warm to touch; on 6/2/06. Rx Benadryl 12-5/5 1/2 tsp PO TID.
rash as the size of a half dollar; warm to the touch and ongoing; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number 4RF5J, expiry date 25th April 2022) and (batch number 57EE5, expiry date 25th April 2022) for prophylaxis.   On 29th May 2020, the patient received the 1st dose of Shingrix. On an unknown date, the dose was an unknown dose. On an unknown date, 1 week after receiving Shingrix, the patient experienced rash and skin warm. On an unknown date, the outcome of the rash and skin warm were recovered/resolved.   It was unknown if the reporter considered the rash and skin warm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number was reported as 4RS5J, however was changed to 4RF5J as per sales data sheet. the patient received Shingrix batch. The patient experienced a rash as the size of a half dollar, warm to the touch, and ongoing approximately one week after receiving dose one of Shingrix.  The reporter consented to follow up.
side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects). At the time of the report, VACCINATION COMPLICATION (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported. No specific verbatim terms were discussed.
Developed arthralgia, sore knees 2 weeks post 4th vax, pain persists for 3 weeks.
This spontaneous report as received from a healthcare worker (medical assistant) refers to a patient of unknown age and gender. On 27-May-2014 the patient was vaccinated with an expired first dose of MMR II (dose and route unknown) lot # H009782, expiry date 15-MAY-2014. No adverse symptoms were reported. The healthcare worker stated that MMR II had no previous temperature excursions. Additional information has been requested.